Ilari Mäki-Opas

Latest publications

• TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma

  Mäki-Opas, I., Hämäläinen, M., Moilanen, E. & Scotece, M., 2023, In: Arthritis Research and Therapy. 25, 1, 12.

  Research output: Contribution to journal › Article › Scientific › peer-review

• TRPA1 Mediates Contact Hypersensitivity Induced by 2,4-Dinitrochlorobenzene

  Mäki-Opas, I., Hämäläinen, M., Moilanen, L. J., Sood, H., Leppänen, T., Kummola, L., Junttila, I. S., Lehtimäki, L. & Moilanen, E., 2023, In: Journal of Investigative Dermatology. 143, 6, p. 1104-1108.e4

  Research output: Contribution to journal › Letter › Scientific › peer-review

• Pyrazine-Fused Triterpenoids Block the TRPA1 Ion Channel in Vitro and Inhibit TRPA1-Mediated Acute Inflammation in Vivo

  Mäki-Opas, I., Hämäläinen, M., Moilanen, L. J., Haavikko, R., Ahonen, T. J., Alakurtti, S., Moreira, V. M., Muraki, K., Yli-Kauhaluoma, J. & Moilanen, E., 2019, In: ACS Chemical Neuroscience. 10, 6, p. 2848-2857

  Research output: Contribution to journal › Article › Scientific › peer-review

• Natural Stilbenoids Have Anti-Inflammatory Properties in Vivo and Down-Regulate the Production of Inflammatory Mediators NO, IL6, and MCP1 Possibly in a PI3K/Akt-Dependent Manner

  Eräsalo, H., Hämäläinen, M., Leppänen, T., Mäki-Opas, I., Laavola, M., Haavikko, R., Yli-Kauhaluoma, J. & Moilanen, E., 2018, In: Journal of natural products. 81, 5, p. 1131-1142

  Research output: Contribution to journal › Article › Scientific › peer-review